My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 96

    1.

    Off-label psychopharmacologic prescribing for children: History supports close clinical monitoring.

    Zito JM, Derivan AT, Kratochvil CJ, Safer DJ, Fegert JM, Greenhill LL.

    Child Adolesc Psychiatry Ment Health. 2008 Sep 15;2(1):24.PMID: 18793403 [PubMed - in process]Related articlesFree article

    2.

    [Off-label use of psychotropic medications in pediatric wards: a prospective study]

    Winterfeld U, Le Heuzey MF, Acquaviva E, Mouren MC, Brion F, Bourdon O.

    Arch Pediatr. 2009 Sep;16(9):1252-60. Epub 2009 Jul 28. French. PMID: 19640689 [PubMed - indexed for MEDLINE]Related articles

    3.

    Off-label psychotropic prescribing for young persons in medium security.

    Haw C, Stubbs J.

    J Psychopharmacol. 2009 May 7. [Epub ahead of print]PMID: 19423609 [PubMed - as supplied by publisher]Related articles

    4.

    Off-label use of antipsychotics: are we mad?

    Haw C, Stubbs J.

    Expert Opin Drug Saf. 2007 Sep;6(5):533-45. Review.PMID: 17877441 [PubMed - indexed for MEDLINE]Related articles

    5.

    Off-label and unlicensed drug prescribing in three paediatric wards in Finland and review of the international literature.

    Lindell-Osuagwu L, Korhonen MJ, Saano S, Helin-Tanninen M, Naaranlahti T, Kokki H.

    J Clin Pharm Ther. 2009 Jun;34(3):277-87. Review.PMID: 19650250 [PubMed - indexed for MEDLINE]Related articles

    6.

    Prioritizing future research on off-label prescribing: results of a quantitative evaluation.

    Walton SM, Schumock GT, Lee KV, Alexander GC, Meltzer D, Stafford RS.

    Pharmacotherapy. 2008 Dec;28(12):1443-52.PMID: 19025425 [PubMed - indexed for MEDLINE]Related articles

    7.

    [Drawing up guidelines for the attendance of physical health of patients with severe mental illness]

    Saravane D, Feve B, Frances Y, Corruble E, Lancon C, Chanson P, Maison P, Terra JL, Azorin JM; avec le soutien institutionnel du laboratoire Lilly.

    Encephale. 2009 Sep;35(4):330-9. Epub 2009 Jul 9. French. PMID: 19748369 [PubMed - indexed for MEDLINE]Related articles

    8.

    Drug monitoring in child and adolescent psychiatry for improved efficacy and safety of psychopharmacotherapy.

    Mehler-Wex C, Kölch M, Kirchheiner J, Antony G, Fegert JM, Gerlach M.

    Child Adolesc Psychiatry Ment Health. 2009 Apr 9;3(1):14.PMID: 19358696 [PubMed - in process]Related articlesFree article

    9.

    Off-label prescribing to children in the United States outpatient setting.

    Bazzano AT, Mangione-Smith R, Schonlau M, Suttorp MJ, Brook RH.

    Acad Pediatr. 2009 Mar-Apr;9(2):81-8. Epub 2009 Feb 11.PMID: 19329098 [PubMed - indexed for MEDLINE]Related articles

    10.

    Off-label prescribing of medications for children.

    Monestime-Williams N, Dickerson LM, Basco WT Jr.

    J S C Med Assoc. 2007 Jun;103(5):130-3.PMID: 18333578 [PubMed - indexed for MEDLINE]Related articles

    11.

    The economics of pediatric formulation development for off-patent drugs.

    Milne CP, Bruss JB.

    Clin Ther. 2008 Nov;30(11):2133-45. Review.PMID: 19108801 [PubMed - indexed for MEDLINE]Related articles

    12.

    Off-label use of cardiovascular medications in children hospitalized with congenital and acquired heart disease.

    Pasquali SK, Hall M, Slonim AD, Jenkins KJ, Marino BS, Cohen MS, Shah SS.

    Circ Cardiovasc Qual Outcomes. 2008 Nov;1(2):74-83. Epub 2008 Nov 5.PMID: 20031793 [PubMed - in process]Related articlesFree article

    13.

    Outcomes and complications with off-label use of drug-eluting stents: results from the STENT (Strategic Transcatheter Evaluation of New Therapies) group.

    Brodie BR, Stuckey T, Downey W, Humphrey A, Bradshaw B, Metzger C, Hermiller J, Krainin F, Juk S, Cheek B, Duffy P, Smith H, Edmunds J, Varanasi J, Simonton CA; STENT (Strategic Transcatheter Evaluation of New Therapies) Group.

    JACC Cardiovasc Interv. 2008 Aug;1(4):405-14. Erratum in: JACC Cardiovasc Interv. 2008 Oct;1(5):601. PMID: 19463338 [PubMed - indexed for MEDLINE]Related articles

    14.

    Off-label medication use in an academic hospital pediatric critical care unit.

    Hsu B, Brazelton T.

    WMJ. 2009 Oct;108(7):343-8.PMID: 19886581 [PubMed - indexed for MEDLINE]Related articles

    15.

    Clevidipine: a review of its use in the management of acute hypertension.

    Deeks ED, Keating GM, Keam SJ.

    Am J Cardiovasc Drugs. 2009;9(2):117-34. doi: 10.2165/00129784-200909020-00006. Review.PMID: 19331440 [PubMed - indexed for MEDLINE]Related articles

    16.

    Off-label use of bevacizumab for the treatment of age-related macular degeneration: what is the evidence?

    Ziemssen F, Grisanti S, Bartz-Schmidt KU, Spitzer MS.

    Drugs Aging. 2009;26(4):295-320. doi: 10.2165/00002512-200926040-00002. Review.PMID: 19476398 [PubMed - indexed for MEDLINE]Related articles

    17.

    Frequency of ill-founded off-label prescribing in Dutch general practice.

    Gijsen R, Jochemsen H, van Dijk L, Caspers P.

    Pharmacoepidemiol Drug Saf. 2009 Jan;18(1):84-91.PMID: 19111012 [PubMed - indexed for MEDLINE]Related articles

    18.

    Ethical issues in psychopharmacology of children and adolescents.

    Koelch M, Schnoor K, Fegert JM.

    Curr Opin Psychiatry. 2008 Nov;21(6):598-605. Review.PMID: 18852568 [PubMed - indexed for MEDLINE]Related articles

    20.

    [Off-label use in child and adolescent psychiatry. An ongoing ethical, medical and legal problem]

    Kölch M, Allroggen M, Fegert JM.

    Nervenarzt. 2009 Jul;80(7):789-96. Review. German. PMID: 19533077 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination
    Write to the Help Desk